An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers
Clinical Trial ID: NCT03964168
Description
Patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider.
Retrospective chart review and patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider. This research intends to improve the continuity of care by determining why patients stop therapy and what can be done to improve their experience with the provider, pharmaceutical companies and specialty pharmacies.
Criteria
Inclusion Criteria: - Male or female adults ≥ 18 years of age. - Was receiving first or second biologic therapy - Has not had a follow up with treating physician in ≥ 9 months Exclusion Criteria: - Actively receiving biologic therapy - Was not receiving first or second biologic therapy
Start Date
2019-05-14
Last Updated
2019-05-24
Sponsor
Janssen Scientific Affairs, LLC
Condition Name
Psoriasis
Learn about this trial.
Check the eligibility requirements, study details, and more.
Related Trials
Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.